Ideaya Biosciences Inc’s filing revealed that its Former Officer Jason Throne acquired Company’s shares for reported $3.02 million on Aug 26 ’24. In the deal valued at $40.22 per share,75,000 shares were bought.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, WHITE MICHAEL ANTHONY sold 28,500 shares, generating $1,032,884 in total proceeds. Upon selling the shares at $36.24, the Chief Scientific Officer now owns 0 shares.
Before that, Hata Yujiro S sold 83,856 shares. Ideaya Biosciences Inc shares valued at $3,597,756 were divested by the President and CEO at a price of $42.90 per share. As a result of the transaction, Hata Yujiro S now holds 677,887 shares, worth roughly $17.53 million.
Stephens initiated its Ideaya Biosciences Inc [IDYA] rating to an Overweight in a research note published on November 18, 2024; the price target was $51. A number of analysts have revised their coverage, including Leerink Partners’s analysts, who decreased its forecast for the stock in early November from “an Outperform” to “a Market perform”. UBS began covering IDYA with “Buy” recommendation on October 24, 2024. Cantor Fitzgerald started covering the stock on October 15, 2024. It rated IDYA as “an Overweight”.
Price Performance Review of IDYA
On Tuesday, Ideaya Biosciences Inc [NASDAQ:IDYA] saw its stock fall -1.26% to $25.86. Over the last five days, the stock has lost -16.53%. Ideaya Biosciences Inc shares have fallen nearly -27.32% since the year began. Nevertheless, the stocks have fallen -14.85% over the past one year. While a 52-week high of $47.74 was reached on 02/15/24, a 52-week low of $25.62 was recorded on 11/18/24. SMA at 50 days reached $31.00, while 200 days put it at $38.28.
Levels Of Support And Resistance For IDYA Stock
The 24-hour chart illustrates a support level at 25.55, which if violated will result in even more drops to 25.25. On the upside, there is a resistance level at 26.36. A further resistance level may holdings at 26.87. The Relative Strength Index (RSI) on the 14-day chart is 31.73, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -3.03, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 96.60%. Stochastics %K at 5.08% indicates the stock is a buying.
How much short interest is there in Ideaya Biosciences Inc?
A steep rise in short interest was recorded in Ideaya Biosciences Inc stocks on 2024-10-31, dropping by -2.77 million shares to a total of 9.31 million shares. Yahoo Finance data shows the prior-month short interest on 2024-09-30 was 12.08 million shares. There was a decline of -29.76%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on July 08, 2024 when Mizuho began covering the stock and recommended ‘”an Outperform”‘ rating along with a $50 price target.
